Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study
Javier Trujillo‐Santos(Santa Lucía University General Hospital), Rosa López, Eva Martínez de Castro(Marqués de Valdecilla University Hospital), Anna Bustins, Ignacio Escobar(Hospital Universitario 12 De Octubre), Miriam Lobo(Hospital General Universitario De Valencia), Isaura Fernández, Esteve Colomé(Leo Pharma (Australia)), Ferràn Torres(Evidence (Italy)), Carmen Díaz‐Pedroche(Universidad Complutense de Madrid), Pere Pascual i Domènech(Bellvitge University Hospital), Y. Lage(Instituto Ramón y Cajal de Investigación Sanitaria), Javier García‐Sánchez, Fernando Garicano(Hospital de Galdakao), David Gutiérrez-Abad, Elena Brozos-Vázquez, Rut Porta Balanyà(Catalan Institute for Water Research), Raquel Molina(Hospital Universitario Príncipe de Asturias), Elena Cillán, Silvia García Adrián(Hospital Universitario de Móstoles), Francisco Expósito, José Carlos Benítez(Hospital Regional Universitario de Málaga), Sara Agraso, Maite Antonio, António Araújo(Administração Regional de Saúde de Lisboa e Vale do Tejo), V.E. Castellón Rubio(Complejo Hospitalario Torrecárdenas), M. Biosca(Vall d'Hebron Hospital Universitari), Mercedes Salgado Fernández(Complejo Hospitalario de Ourense), Irene González-Cebrián, Geòrgia Anguera(Hospital de Sant Pau), Manuel González-Moya, Sandra Giménez, Carme Font(Hospital Clínic de Barcelona), Enrique Gallardo(Marqués de Valdecilla University Hospital), Clara Lucía Gozálvez, Víctor Sapena(Hospital Clínic de Barcelona), Tomeu Fullana, Pablo Cerezuela(Instituto Murciano de Investigación Biosanitaria), Ana Lúcia Costa(Centro Hospitalar Lisboa Norte), Marta Carmona(Instituto de Investigación Sanitaria de Santiago), Begoña Campos, Núria Calvo, Mariana Malheiro(Centro Hospitalar de Lisboa Ocidental), Diego Cacho, Paula Espinosa Olarte, Lourdes Fernández-Franco, Ana Blasco(Hospital General Universitario De Valencia)
Cited by 1
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation
|Journal of Hepatology|2018|291
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
|The Lancet Oncology|2011|221
FGFR a promising druggable target in cancer: Molecular biology and new drugs
|Critical Reviews in Oncology/Hematology|2017|203